Cargando…
Incobotulinum Toxin Type A for Treatment of Ultraviolet-B-Induced Hyperpigmentation: A Prospective, Randomized, Controlled Trial
Incobotulinum toxin A (IncoBoNT-A) is effective in preventing ultraviolet B (UVB)-induced hyperpigmentation. This prospective, randomized, controlled study aimed to evaluate the effect of IncoBoNT-A on the treatment of UVB-induced hyperpigmentation in 15 volunteers. Five hyperpigmentation squares (2...
Autores principales: | Vachiramon, Vasanop, Anuntrangsee, Tanaporn, Palakornkitti, Pasita, Jurairattanaporn, Natthachat, Harnchoowong, Sarawin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231130/ https://www.ncbi.nlm.nih.gov/pubmed/35737078 http://dx.doi.org/10.3390/toxins14060417 |
Ejemplares similares
-
The role of topical capsaicin gel in pain management during microfocused ultrasound treatment for neck laxity
por: Vachiramon, Vasanop, et al.
Publicado: (2022) -
Efficacy of Botulinum Toxin Type A for Prevention of Post-Mastectomy Scar in Transmen: A Prospective, Randomized Study
por: Winayanuwattikun, Waranaree, et al.
Publicado: (2023) -
Dermal Pathology in Melasma: An Update Review
por: Phansuk, Kachanat, et al.
Publicado: (2022) -
Prevalence of Thyroid Abnormalities in Thai Patients with Vitiligo
por: Vachiramon, Vasanop, et al.
Publicado: (2017) -
Prevalence and Clinical Characteristics of Itch in Vitiligo and Its Clinical Significance
por: Vachiramon, Vasanop, et al.
Publicado: (2017)